Concepedia

Author

Joan Houghton

University College London

Also Known As

Joan Houghton

21

Publications

2.6K

Citations

13

H-Index

30

Concepts

All Affiliations

University College LondonKing's College HospitalThe Royal Free HospitalMRC Clinical Trials Unit at UCLRoyal Marsden Hospital
JH

About

Joan Houghton is an author at University College London specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

1.6K

2

Health Sciences

2

2

129

3

Nursing

1

1

30

4

Family Medicine

1

1

30

5

Gastroenterology

1

1

702

Joan Houghton

×

10

Publications

2.4K

Citations

10

H-Index

YearCitations

RANDOMISED TRIAL OF ENDOSCOPIC VERSUS PERCUTANEOUS STENT INSERTION IN MALIGNANT OBSTRUCTIVE JAUNDICE

AntonyG. Speer, Roche Christopher, Greg Russell,

The Lancet

1987

702

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial

Joan Houghton

The Lancet

2003

593

Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial

Mitch Dowsett, Craig Allred, Jill Knox,

Journal of Clinical Oncology

2008

463

Retrospective Analysis of Time to Recurrence in the ATAC Trial According to Hormone Receptor Status: An Hypothesis-Generating Study

Mitch Dowsett, Jack Cuzick, Chris Wale,

Journal of Clinical Oncology

2005

264

Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for ‘well-tolerated’ treatments?

Deborah Fellowes, Lesley Fallowfield, Christobel Saunders,

Breast Cancer Research and Treatment

2001

99

Cancer growth, response to treatment and survival time in mice: Beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen

A. B. Bennett, Joan Houghton, David Leaper,

Prostaglandins

1979

97

Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost

Jayant S. Vaidya, Michael Baum, Jeffrey Tobias,

International Journal of Radiation Oncology*Biology*Physics

2006

81

Results of the Cancer Research Campaign Adjuvant Trial for Perioperative Cyclophosphamide and Long-Term Tamoxifen in Early Breast Cancer Reported at the Tenth Year of Follow-Up

Michael Baum, Joan Houghton, Diana Riley

Acta Oncologica

1992

35

p53 and P-glycoprotein expression are significant prognostic markers in advanced head and neck cancer treated with chemo/radiotherapy

Saman Warnakulasuriya, Chaoying Jia, Newell W. Johnson,

The Journal of Pathology

2000

30

Trials and tribulations: thoughts on the organisation of multicentre clinical studies.

Michael Baum, Diana Brinkley, C. Elston,

BMJ

1980

30

Page 1